University of Palermo
🇮🇹Italy
- Country
- 🇮🇹Italy
- Ownership
- Private
- Established
- 1806-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://portale.unipa.it
Clinical Trials
127
Active:3
Completed:80
Trial Phases
5 Phases
Phase 1:2
Phase 2:2
Phase 3:4
+2 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (77 trials with phase data)• Click on a phase to view related trials
Not Applicable
50 (64.9%)Phase 4
19 (24.7%)Phase 3
4 (5.2%)Phase 1
2 (2.6%)Phase 2
2 (2.6%)The Effects of Foam Rolling on Ankle Dorsiflexion, Ankle Stability, and Athletic Performance in Rhythmic Gymnasts
Not Applicable
Completed
- Conditions
- Athletes
- First Posted Date
- 2025-08-08
- Last Posted Date
- 2025-08-17
- Lead Sponsor
- University of Palermo
- Target Recruit Count
- 26
- Registration Number
- NCT07113249
- Locations
- 🇮🇹
University of Palermo, Palermo, Italy
Ketogenic vs. Mediterranean Diet on Metabolic and Hormonal Parameters in Patients With Active Acromegaly
Not Applicable
Completed
- Conditions
- Acromegaly
- First Posted Date
- 2025-08-03
- Last Posted Date
- 2025-08-03
- Lead Sponsor
- University of Palermo
- Target Recruit Count
- 25
- Registration Number
- NCT07100587
- Locations
- 🇮🇹
Policlinico Paolo Giaccone, Palermo, Italy
Mucoadhesive Modified-Release Formulations for the Topical Treatment of Symptomatic Oral Lichen Planus
Not Applicable
Recruiting
- Conditions
- Oral Lichen PlanusOral Lichen Planus Related StressOral Mucosal DiseaseOral Pain
- Interventions
- Drug: Clobetasol PatchDrug: Clobetasol + Resveratrol PatchDrug: Clobetasol in Orabase
- First Posted Date
- 2025-08-03
- Last Posted Date
- 2025-08-03
- Lead Sponsor
- University of Palermo
- Target Recruit Count
- 45
- Registration Number
- NCT07100613
- Locations
- 🇮🇹
University of Palermo, Palermo, Italy
Oral vs. Subcutaneous Semaglutide in Type 2 Diabetes Mellitus
Completed
- Conditions
- Diabetes Mellitus Type 2
- Interventions
- Drug: subcutaneous semaglutide
- First Posted Date
- 2025-07-09
- Last Posted Date
- 2025-07-17
- Lead Sponsor
- University of Palermo
- Target Recruit Count
- 212
- Registration Number
- NCT07056803
- Locations
- 🇮🇹
Policlinico Paolo Giaccone, Palermo, Italy
Does The Addition Of Letrozole To Ultra-Long GnRH Agonists Help Adenomyosis Patients in ART? The AURA Trial
Phase 4
Not yet recruiting
- Conditions
- Adenomyosis of UterusInfertility Assisted Reproductive Technology
- Interventions
- Drug: Ultra-Long GnRH AgonistsDrug: Ultra-Long GnRH Agonists + Letrozole
- First Posted Date
- 2025-05-22
- Last Posted Date
- 2025-05-29
- Lead Sponsor
- University of Palermo
- Target Recruit Count
- 162
- Registration Number
- NCT06985186
- Locations
- 🇪🇸
Instituto Bernabeu, Alicante, Spain
- Prev
- 1
- 2
- 3
- 4
- 5
- 26
- Next
News
No news found